20
2007
Midkine - a potential therapeutic target in melanoma.

Göran Jönsson , Marco Donia
Pigment Cell & Melanoma Research

2021
PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanoma.

Dan Grandér , Sakari Kauppinen , Katja Pokrovskaja Tamm , Per Johnsson
Scientific Reports 11 ( 1) 11023

2021
Identification of Subtypes in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Reveals a Gene Signature Prognostic of Outcome

Johan Staaf , Markus Ringnér , Johan Vallon-Christersson , Göran Jönsson
Journal of Clinical Oncology 28 ( 11) 1813 -1820

136
2010
A new look at drugs targeting malignant melanoma--an application for mass spectrometry imaging.

Yutaka Sugihara , Ákos Végvári , Charlotte Welinder , Göran Jönsson
Proteomics 14 1963 -1970

22
2014
MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment.

Stefanie Riesenberg , Angela Groetchen , Robert Siddaway , Tobias Bald
Nature Communications 6 ( 1) 8755 -8755

118
2015
Different cell cycle kinetic effects of N1,N11-diethylnorspermine-induced polyamine depletion in four human breast cancer cell lines.

Louise Myhre , Kersti Alm , Cecilia Hegardt , Johan Staaf
Anti-Cancer Drugs 19 ( 4) 359 -368

14
2008
Molecular mechanisms underlying N1, N11-diethylnorspermine-induced apoptosis in a human breast cancer cell line.

C. Martina Holst , Johan Staaf , Göran Jönsson , Cecilia Hegardt
Anti-Cancer Drugs 19 ( 9) 871 -883

9
2008
Mutational and gene fusion analyses of primary large cell and large cell neuroendocrine lung cancer.

Anna Karlsson , Hans Brunnström , Kajsa Ericson Lindquist , Karin Jirström
Oncotarget 6 ( 26) 22028 -22037

63
2015
Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4.

Peter Johansson , Lauren G. Aoude , Karin Wadt , William J. Glasson
Oncotarget 7 ( 4) 4624 -4631

255
2016
WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells

Elin J Ekström , Caroline Bergenfelz , Verena von Bülow , Filiz Serifler
Molecular Cancer 13 ( 1) 88 -88

144
2014
Escape from nonsense-mediated decay associates with anti-tumor immunogenicity.

Kevin Litchfield , James L. Reading , Emilia L. Lim , Hang Xu
Nature Communications 11 ( 1) 3800 -3800

8
2020
Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer

Anna Larsson , Marie Fridberg , Alexander Gaber , Björn Nodin
BMC Cancer 12 ( 1) 282 -282

36
2012
Low BRAF and NRAS expression levels are associated with clinical benefit from DTIC therapy and prognosis in metastatic melanoma

Einar Birkeland , Christian Busch , Elisabet Ognedal Berge , Jürgen Geisler
Clinical & Experimental Metastasis 30 ( 7) 867 -876

16
2013
High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer

Ida Johansson , Cecilia Nilsson , Pontus Berglund , Carina Strand
Breast Cancer Research and Treatment 129 ( 3) 747 -760

57
2011
28
2017
Monitoring of technical variation in quantitative high-throughput datasets.

Martin Lauss , Ilhami Visne , Albert Kriegner , Markus Ringnér
Cancer Informatics 12 ( 12) 193 -201

44
2013
Establishing a Southern Swedish Malignant Melanoma OMICS and Biobank Clinical Capability

Charlotte Welinder , Göran Jönsson , Christian Ingvar , Lotta Lundgren
Clinical and translational medicine 2 ( 1) 7 -7

17
2013
Inherited variation in the PARP1 gene and survival from melanoma

John R Davies , Rosalyn Jewell , Paul Affleck , Gabriella M Anic
International Journal of Cancer 135 ( 7) 1625 -1633

21
2014